Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 85Osteosarcoma 30Neuroectodermal Tumors, Primitive, Peripheral 16Fibrosarcoma 16Rhabdomyosarcoma 14Liposarcoma 14Hemangiosarcoma 13Neurofibrosarcoma 12Leiomyosarcoma 12Histiocytoma, Malignant Fibrous 12Sarcoma, Synovial 11Malignant mesenchymal tumor 9Sarcoma, Ewing 8Ovarian Neoplasms 8Hemangiopericytoma, Malignant 8Kidney Neoplasms 6Dendritic Cell Sarcoma, Interdigitating 6Wilms Tumor 5Sarcoma, Alveolar Soft Part 5Neoplasms 5Desmoplastic Small Round Cell Tumor 5Chondrosarcoma 5Carcinoma, Renal Cell 5Neuroblastoma 4Neoplasm Metastasis 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Dermatofibrosarcoma 4Chondrosarcoma, Extraskeletal Myxoid 4Central Nervous System Neoplasms 4

Interventions

sargramostim 1indolepropanol phosphate 1Vincristine 1Tirapazamine 1Pharmacogenomic Testing 1Irinotecan 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Alveolar Childhood Rhabdomyosarcoma × Ifosfamide × Sarcoma × Clear all
NCT00025363 2013-01-17

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
150 enrolled
Sarcoma

Alveolar Childhood Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡